Mallinckrodt (MNK) Tops Q3 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- S&P 500 ends down after Trump says Iran deal is 'over'
- Oil settles at multi-week high as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
Leerink Partners Upgrades Mallinckrodt plc (MNK) to Outperform on Valuation
August 6, 2015 2:40 PM EDTLeerink Partners upgraded Mallinckrodt plc (NYSE: MNK) from Market Perform to Outperform with a price target of $112. Analyst Jason M. Gerberry tied the upgrade to valuation.
"We are upgrading MNK on valuation as the stocks recent plummet post F3Q has created a buying opportunity, in our... More
Piper Jaffray Cuts Price Target on Mallinckrodt (MNK) to $140 Following 3Q EPS Beat
August 5, 2015 9:40 AM EDTPiper Jaffray reiterated an Overweight rating on Mallinckrodt plc (NYSE: MNK), and cut the price target to $140.00 (from $150.00), following 3Q15 results. Mallinckrodt reported 3Q15 diluted EPS of $2.05, ahead of the Street estimate of $1.83. Revenues of $965M missed the Street's $986M estimate.
Analyst David Amsellem commented, "Mallinckrodt reported fiscal... More
Mallinckrodt (MNK) PT, Estimates Lowered at Leerink Partners Following Mixed Q3
August 5, 2015 7:48 AM EDTLeerink Partners analyst Jason Gerberry lowered estimates and his price target on Market Perform-rated Mallinckrodt plc (NYSE: MNK) to $112.00 (from $133.00) following mixed Q3 results that included a ~$20m miss on consensus due to weaker than expected Acthar (autoimmune disease) and oxycodone Gx... More
JPMorgan Downgrades Mallinckrodt plc (MNK) to Neutral
August 5, 2015 7:10 AM EDTJPMorgan downgraded Mallinckrodt plc (NYSE: MNK) from Overweight to Neutral with a price target of $120.00 (from $140.00).
For an analyst ratings summary and ratings history on Mallinckrodt plc click here. For more ratings news on Mallinckrodt plc click here.
Shares of Mallinckrodt plc closed at $106.73 yesterday.
... More